FINWIRES · TerminalLIVE
FINWIRES

賈登表示,雷吉斯醫療保健公司將受益於老年護理資金改革

-- 根據Jarden週四發布的一份報告顯示,Regis Healthcare(ASX:REG)有望受益於政府撥款增加、住宿補貼調整以及擬議的養老護理改革中的發展激勵措施。 由於嬰兒潮世代老化帶來的日益增長的需求超過了有限的新增供應,養老護理行業持續面臨壓力,導致入住率創歷史新高,並促使養老機構轉向收費更高的非優惠居民以提高財務回報。 Jarden表示,衛生部長馬克巴特勒在聯邦預算案公佈前提出的住宿價格審查改革總體上是積極的,好於此前僅小幅提高住宿補貼的預期。 改革措施包括將每位居民每天的住宿補貼增加5澳元,並建立新的分級制度,提高優惠居民比例在30%至39%和60%以上的養老院的撥款,取代此前鼓勵運營商將優惠居民比例保持在40%以下的激勵措施。 另一項重要改革是取消可退還住宿押金定價的最高允許利率,Jarden認為此舉有利於供應商在設定轉換率方面擁有更大的靈活性,並增強現金流的穩定性。 該公司估計,這些改革措施的綜合影響可能為公司帶來約700萬澳元的年度稅前收益成長,相當於2027財年預期利潤將達到個位數百分比的中等成長。 該公司指出,這項審查提議為養老護理項目提供長期每日付款和每年20億澳元的無息貸款,這可以支持公司九個新建項目,在資金緊張的情況下新增約1200張床位。 Jarden維持對Regis Healthcare的「增持」評級,目標股價為8.50澳元。

Related Articles

Asia

Clinuvel Unlikely to Seek Scenesse's Vitiligo Approval Before Phase 3 Completion, Says Jefferies

Clinuvel Pharmaceuticals (ASX:CUV) is unlikely to seek regulatory approval for Scenesse in vitiligo until the Phase 3 CUV105 and CUV107 clinical trials are completed, according to a Friday Jefferies note.The company said on Friday that the European Medicines Agency (EMA) has proposed evaluating the company's Scenesse drug for the treatment of systemic vitiligo based on a "totality of evidence" regulatory approach.Jefferies said that the EMA's decision is a positive for the company because of the high unmet medical need for Vitiligo treatment.The investment firm has pushed back its revenue expectations from Scenesse in vitiligo, which is now expected to begin in the second half of fiscal 2029 rather than fiscal 2028.Jefferies kept a buy rating on Clinuvel and cut its price target to AU$39.20 from AU$40.50.

$ASX:CUV
Asia

ASX Preview: Australian Shares Set to Open Flat on Stalled US-Iran Talks; Origin Energy Reports Lower March Quarter Production

Australian shares are set to open flat on Monday, as oil prices climbed almost 2% following stalled US-Iran peace negotiations and restricted flows through the Strait of Hormuz, tightening global supply and pushing Brent crude above $107 a barrel.On April 25, the S&P 500 and the Nasdaq Composite rose 0.8% and 1.6%, respectively, while the Dow Jones Industrial Average fell 0.2%.In the macroeconomy, investors are eyeing the release of Australia's consumer price index report on Wednesday.In corporate news, Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.IperionX's (ASX:IPX) titanium powder production operations in Virginia, US, transitioned to an around-the-clock production schedule during the March quarter, advancing from commissioning to continuous operations, according to a Monday filing with the Australian bourse.Australia's benchmark index fell 0.1% or 6.9 points to close at 8,786.50 on April 24.

$^AXJO$ASX:IPX$ASX:ORG
Asia

Cobre Appoints Chief Financial Officer

Cobre (ASX:CBE) has appointed Kaveen Bachoo as chief financial officer, effective April 28, according to a Monday filing with the Australian bourse.Bachoo has over 20 years of finance leadership experience in the mining sector, including executive positions at Glencore.

$ASX:CBE